title: [Case report of kidney cancer from JOUM 2010].
abstract: Three clinical cases have shown the superiority of sunitinib in first line therapy intermediate risk metastatic clear cell renal carcinoma and a best safety of bevacizumab plus interferon, the current lack of high level of evidence arguments for the neo-adjuvant treatment of kidney cancer, the importance to prevent mucositis during a mTOR inhibitors treatment and the diagnostic pitfalls of its pulmonary complications.
authors.affiliation: Service d'Urologie, Hôpital Foch, 40, rue Worth, 92151 Suresnes, France.
authors.forename: Y
authors.initials: Y
authors.lastname: Neuzillet
authors.forename: L
authors.initials: L
authors.lastname: Guy
authors.forename: J-A
authors.initials: JA
authors.lastname: Long
authors.forename: L
authors.initials: L
authors.lastname: Zini
authors.forename: C
authors.initials: C
authors.lastname: Chevreau
authors.forename: B
authors.initials: B
authors.lastname: Duclos
authors.forename: B
authors.initials: B
authors.lastname: Escudier
authors.forename: P
authors.initials: P
authors.lastname: Gimel
authors.forename: F
authors.initials: F
authors.lastname: Joly
authors.forename: H
authors.initials: H
authors.lastname: Lang
authors.forename: A
authors.initials: A
authors.lastname: Mejean
authors.forename: S
authors.initials: S
authors.lastname: Oudard
authors.forename: T
authors.initials: T
authors.lastname: Roumeguere
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged